2026 IPO stock tracker: How biotechs new to public markets are performing
BioSpace is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026.
News Archive
Browse all past biotechnology intelligence, clinical developments, and industry updates.
Archived Updates
5 emerging biotech hubs
Fierce Biotech profiles five emerging biotech hubs to watch.
ANF Care™ Brings New Wearable Technology to the United States
ANF Care announced US market entry for its ANF Care wearable therapeutic device, expanding availability of its frequency-based wearable technology to American patients and clinicians.
APhA urges FDA to put patient safety first in review of peptide substances
The American Pharmacists Association (APhA) submitted formal comments to the FDA urging the agency to prioritize patient safety in its ongoing review of peptide substances, including compounded and bulk-drug substances.
Arbutus, Sanofi escalate mRNA patent fights; InnoCare's TYK2 contender advances
Arbutus, Sanofi escalate mRNA patent fights; InnoCare's TYK2 contender advances.
BlossomHill eyes IPO to grow taller in crowded cancer fields
BlossomHill eyes IPO to grow taller in crowded cancer fields.
BRIJ Medical Launches BRIJ-SEAL™, Expanding Its Incision Management Portfolio with New Topical Skin Closure Solution
BRIJ Medical announced the US launch of BRIJ-SEAL™, a topical skin closure product, expanding the company's incision management portfolio alongside its existing wound-closure and post-operative care products.
BRIJ Medical Launches BRIJ-SEAL™, Expanding Its Incision Management Portfolio with an Advanced Wound Sealant
BRIJ Medical Launches BRIJ-SEAL™, Expanding Its Incision Management Portfolio with an Advanced Wound Sealant.
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
Camurus announces that the FDA has accepted for review its NDA resubmission for CAM2029 in acromegaly.
Can the shingles vaccine prevent Alzheimer's? GSK has a big study to find out
GSK launches a large study to test whether the shingles vaccine can prevent dementia.
Can ultrasound unlock the power of gene therapy? A startup makes big claims
Sonathera claims ultrasound can unlock the power of gene therapy in Duchenne and other diseases.
Cue lines up new CMO and research head—Chutes & Ladders
Cue Health lines up a new CMO and research head in the latest Chutes & Ladders roundup.
Cue lines up new CMO and research head—Chutes & Ladders
Cue Health lines up a new CMO and research head in the latest Chutes & Ladders roundup.
Dimerix buys a kidney injury drug; Arpeggio appears to be winding down
Dimerix buys a kidney injury drug from Mission; Arpeggio appears to be winding down.
Dimerix buys Mission's kidney disease prospect in $292M deal
Dimerix acquires Mission Therapeutics' kidney disease prospect for $292M with $5M upfront.